Skip navigation

Advanced Methods for Medical Writing, Lay Summary Implementation and Improving Communication with Patients

September 24-25, 2018
  • Philadelphia, PA

With impending EU regulations for lay summary requirements expected for 2019, there is no better time to join your colleagues from across the bio/pharma industry at the Annual Lay Summaries Summit!

At CBI’s 3rd Annual Lay Summaries Summit, learn innovative ways to implement lay summaries into your organization, new distribution techniques and how others are translating lay summaries into various languages and dialects. Listen to case studies to understand the best practices for writing non-promotional, accurate lay summaries.

Key Attendee Benefits:

  • Gain in-depth and practical strategies for translating
    endpoints of clinical trials
  • Discuss who is in charge of reviewing the publications and
    how much time they are given to review
  • Keep pace with regulatory requirements for lay summaries
  • Ensure patient needs are being addressed when
    writing summaries
  • Hear case studies for implementing lay summary processes
  • Evaluate the effectiveness of various distribution methods
  • Identify ways to maintain clinical trial content while
    converting lay summaries into different languages
  • Learn how new technology is changing the way
    clinical trial results are distributed to patients

Previous Attendee Acclaim:

I enjoyed networking with new colleagues who are
navigating the same processes.

Sr. Medical Writer, Amgen

After attending this conference, I feel much better informed,
I have knowledgeable contacts to consult, and I am much
better prepared to tackle my next project.

R&D Senior Analyst, Process Lead – Lay Summaries, Sanofi US

Overall, very well conducted.

Senior Medical Writer, Kinapse

Very informative with excellent and well-informed speakers.

Amgen

Some good points raised for me to use to follow up for some internal delivery improvement opportunities.

Clinical Trial Transparency Operations Director, AstraZeneca

3rd Annual Lay Summaries Summit

Advanced Methods for Medical Writing, Lay Summary Implementation and Improving Communication with Patients

With impending EU regulations for lay summary requirements expected for 2019, there is no better time to join your colleagues from across the bio/pharma industry at the Annual Lay Summaries Summit!

At CBI’s 3rd Annual Lay Summaries Summit, learn innovative ways to implement lay summaries into your organization, new distribution techniques and how others are translating lay summaries into various languages and dialects. Listen to case studies to understand the best practices for writing non-promotional, accurate lay summaries.

Key Attendee Benefits:

  • Gain in-depth and practical strategies for translating
    endpoints of clinical trials
  • Discuss who is in charge of reviewing the publications and
    how much time they are given to review
  • Keep pace with regulatory requirements for lay summaries
  • Ensure patient needs are being addressed when
    writing summaries
  • Hear case studies for implementing lay summary processes
  • Evaluate the effectiveness of various distribution methods
  • Identify ways to maintain clinical trial content while
    converting lay summaries into different languages
  • Learn how new technology is changing the way
    clinical trial results are distributed to patients

Previous Attendee Acclaim:

I enjoyed networking with new colleagues who are
navigating the same processes.

Sr. Medical Writer, Amgen

After attending this conference, I feel much better informed,
I have knowledgeable contacts to consult, and I am much
better prepared to tackle my next project.

R&D Senior Analyst, Process Lead – Lay Summaries, Sanofi US

Overall, very well conducted.

Senior Medical Writer, Kinapse

Very informative with excellent and well-informed speakers.

Amgen

Some good points raised for me to use to follow up for some internal delivery improvement opportunities.

Clinical Trial Transparency Operations Director, AstraZeneca